Review
Open access
Aug 2026
Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches
By integrating nanotechnology with immunotherapy, new opportunities arise to convert cold tumors into hot, immune-responsive phenotypes, thereby improving therapeutic efficacy and clinical outcomes.
M. Teiama, Asmaa Gohar, Mahmoud Amr et al.
· Molecular Biomedicine · 0 citations